Evidence map›Paper›PMID 32059381›Full record

ReviewInternational journal of molecular sciences2020

Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases.

Hyung Muk Choi, Hari Madhuri Doss, Kyoung Soo Kim

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 292 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
292citing papers in PubMed, 6 pooled it
36.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

292 citing papers in PubMed, 6 syntheses or guidelines pooled it, 486 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Investigating the Role ofJournal of clinical research in pediatric endocrinology · 2026
    Article
  16. Article
  17. Article
  18. Mechanisms and therapeutic strategies of asthma: from bench to bedside.Signal transduction and targeted therapy · 2026
    Review
  19. Article
  20. Article

232 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hyung Muk ChoiDepartment of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul 02447, Korea.
Hari Madhuri DossDepartment of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul 02447, Korea.
Kyoung Soo KimDepartment of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul 02447, Korea.
Kyung Hee University Hospital at Gangdong · KRKyung Hee University · KR

Funding

Ministry of Health and Welfare HI17C0658National Research Foundation of Korea 2017R1D1AB03031409
6 · The paper itself

Abstract

Adiponectin is the richest adipokine in human plasma, and it is mainly secreted from white adipose tissue. Adiponectin circulates in blood as high-molecular, middle-molecular, and low-molecular weight isoforms. Numerous studies have demonstrated its insulin-sensitizing, anti-atherogenic, and anti-inflammatory effects. Additionally, decreased serum levels of adiponectin is associated with chronic inflammation of metabolic disorders including Type 2 diabetes, obesity, and atherosclerosis. However, recent studies showed that adiponectin could have pro-inflammatory roles in patients with autoimmune diseases. In particular, its high serum level was positively associated with inflammation severity and pathological progression in rheumatoid arthritis, chronic kidney disease, and inflammatory bowel disease. Thus, adiponectin seems to have both pro-inflammatory and anti-inflammatory effects. This indirectly indicates that adiponectin has different physiological roles according to an isoform and effector tissue. Knowledge on the specific functions of isoforms would help develop potential anti-inflammatory therapeutics to target specific adiponectin isoforms against metabolic disorders and autoimmune diseases. This review summarizes the current roles of adiponectin in metabolic disorders and autoimmune diseases.

Indexed as

DiseaseAdaptor Proteins, Signal TransducingAdiponectinAdipose Tissue, WhiteAnimalsAnti-Inflammatory AgentsArthritis, RheumatoidAtherosclerosisAutoimmune DiseasesDiabetes Mellitus, Type 2HumansInflammationInflammatory Bowel DiseasesObesityProtein IsoformsRenal Insufficiency, ChronicAdaptor Proteins, Signal TransducingAdiponectinAnti-Inflammatory AgentsProtein Isoformsadiponectinadiponectin isoformanti-inflammatorychronic kidney disease (CKD)inflammatory bowel disease (IBD)pro-inflammatoryrheumatoid arthritis

Identifiers

PMID32059381
PMCPMC7072842
OpenAlexW3005962890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.